百英生物拟冲刺北交所,辅导券商为海通证券

财经网
11 Feb

近日,上海百英生物科技股份有限公司(以下简称“百英生物”)在上海证监局办理辅导备案,拟向不特定合格投资者公开发行股票并在北交所上市,辅导券商为海通证券。辅导备案报告显示,百英生物曾于2023年6月25日向深交所创业板报送首发上市申请文件,于2023年6月29日获深交所受理,于2024年6月21日向深交所提交撤回申请。百英生物是一家专注于抗体表达和抗体发现与优化业务的CRO公司,主要为生物医药企业...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10